1. Home
  2. VTRS vs CCK Comparison

VTRS vs CCK Comparison

Compare VTRS & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • CCK
  • Stock Information
  • Founded
  • VTRS 1961
  • CCK 1906
  • Country
  • VTRS United States
  • CCK United States
  • Employees
  • VTRS N/A
  • CCK N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • CCK Containers/Packaging
  • Sector
  • VTRS Health Care
  • CCK Industrials
  • Exchange
  • VTRS Nasdaq
  • CCK Nasdaq
  • Market Cap
  • VTRS 13.0B
  • CCK 10.5B
  • IPO Year
  • VTRS N/A
  • CCK N/A
  • Fundamental
  • Price
  • VTRS $11.25
  • CCK $87.30
  • Analyst Decision
  • VTRS Hold
  • CCK Strong Buy
  • Analyst Count
  • VTRS 3
  • CCK 14
  • Target Price
  • VTRS $13.67
  • CCK $104.85
  • AVG Volume (30 Days)
  • VTRS 9.5M
  • CCK 1.5M
  • Earning Date
  • VTRS 02-27-2025
  • CCK 02-05-2025
  • Dividend Yield
  • VTRS 4.27%
  • CCK 1.15%
  • EPS Growth
  • VTRS N/A
  • CCK N/A
  • EPS
  • VTRS N/A
  • CCK 3.55
  • Revenue
  • VTRS $15,048,500,000.00
  • CCK $11,801,000,000.00
  • Revenue This Year
  • VTRS N/A
  • CCK $3.45
  • Revenue Next Year
  • VTRS N/A
  • CCK $2.73
  • P/E Ratio
  • VTRS N/A
  • CCK $24.59
  • Revenue Growth
  • VTRS N/A
  • CCK N/A
  • 52 Week Low
  • VTRS $9.93
  • CCK $70.84
  • 52 Week High
  • VTRS $13.62
  • CCK $98.46
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 52.72
  • CCK 49.90
  • Support Level
  • VTRS $10.74
  • CCK $87.49
  • Resistance Level
  • VTRS $11.02
  • CCK $89.56
  • Average True Range (ATR)
  • VTRS 0.21
  • CCK 2.20
  • MACD
  • VTRS 0.08
  • CCK -0.05
  • Stochastic Oscillator
  • VTRS 91.82
  • CCK 35.80

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About CCK Crown Holdings Inc.

Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

Share on Social Networks: